Published on 20 February 2025
Description:
Achieving inclusivity for minorities in clinical trials; Why local knowledge is key for pharmacovigilance; EU vs US trends in clinical trials
Categories:
Pharmaceutical Market EuropePreview:
28 articles from this collection:
PME February 2025
PME
Comment
Communique Awards 2025
Contents
News
Roche and Ascidian agree to $1.8bn neurological disease partnership
News
Researchers identify new major cause of inflammatory bowel disease
Dermatology News
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
DARWIN'S MEDICINE - Astrategia
The evolutionary lessons for Bayer’s management restructure
MIKE DIXON - What is it all for?
Collecting the right data in the right way for the right reasons
INNOVATIVE IMPACT BLOG - The full potential of patient journeys in pharma
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
HEALTHCARE COMMUNICATIONS - Using impact to show accountability and progress'
PHARMACOVIGILANCE - Why local knowledge is key to global pharmacovigilance outcomes
Across almost every sector, brands are multiplying their investment in creativity
TL ICON - Standing out in a crowded precision oncology landscape
What value does your strategic planning add?
TL FAZE - Why patients ignore your trials –
MARKET TRENDS - Key clinical trial trends – EU vs US perspectives
Picking your omnichannel direction requires a disciplined, scientific approach
NEWS - RARE DISEASE DAY
Ethical content sharing and the benefits of the CLA Pharmaceutical Licence
FlyPharma Amsterdam 2025
TL INTENT HEALTH - Class is the missing link in health equity strategies
PATIENT INCLUSIVITY - Inclusivity, collaboration and targeted care
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
TL Precision Medicine Group - DE&I in clinical trials: the role of health literacy and AI
MARKETING OBJECTIVES - Setting your sights – the marketing objectives
BIOTECH SPIN-OUTS – A PRACTICAL GUIDE - Preparing biotechs for spin-out and beyond
‘Patient engagement is both a process and a behaviour throughout the drug life cycle’
Appointments
Appointments
Appointments
HEALTHCARE COMMS
PharmaRole
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services